News

The Impact Journals news page hosts content about important news articles and press releases from our Journals and Editorial Board Members.

News

Mission
The Impact Journals news page hosts articles about important news stories from our journals and within the scientific community. Visit this page for the latest in medical advances, pharmaceutical progress, conference reports, and more.

LP-284 Targets Non-Hodgkin’s Lymphoma and DNA Damage Repair Deficiency

News

June 12, 2023
PRESS RELEASE: On June 12, 2023, a new research paper was published in Oncotarget, entitled, “LP-284, a small molecule acylfulvene, exerts potent antitumor activity in preclinical non-Hodgkin's lymphoma models and in cells deficient in DNA damage repair.” continue reading »

Targeting the Src N-Terminal Regulatory Element in Cancer

News

June 9, 2023
PRESS RELEASE: On May 19, 2023, Oncotarget published a new research perspective: “Targeting the Src N-terminal regulatory element in cancer.” continue reading »

DNAmFitAge: Biological Age Indicator Incorporating Physical Fitness

News

June 7, 2023
PRESS RELEASE: A new research paper was published in Aging's Volume 15, Issue 10, entitled, “DNAmFitAge: biological age indicator incorporating physical fitness.” continue reading »

Value of Chemotherapy Post Immunotherapy in Stage IV Non-Small Cell Lung Cancer

News

June 7, 2023
PRESS RELEASE: On May 26, 2023, a new research paper was published in Oncotarget, entitled, “Value of chemotherapy post immunotherapy in stage IV non-small cell lung cancer (NSCLC).” continue reading »

BORIS Gene Mutation and Expression: Link to Breast Cancer Progression

News

June 5, 2023
PRESS RELEASE: On May 26, 2023, a new research paper was published in Oncotarget, entitled, “Association of mutation and expression of the brother of the regulator of imprinted sites (BORIS) gene with breast cancer progression.” continue reading »